Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-gamma for sepsis-induced immunoparalysis in septic shock
NL-OMON37057Phase 3Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of interferon gamma-1b in septic shock, sepsis, sponsored by Radboud University Medical Center. Started Nov 2012; status: recruiting.
02
Drugs
interferon gamma-1b
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on NL-OMON37057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37057.